ArticleBMJ (Clinical research ed.)2003
Disclosure of financial competing interests in randomised controlled trials: cross sectional review.
Article in BMJ (Clinical research ed.), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The fading of reported effectiveness. A meta-analysis of randomised controlled trials.BMC medical research methodology · 2006Pooled it
- Review
- The Frequency of Reporting Ethical Issues in Human Subject Articles Published in Iranian Medical Journals: 2009-2013.Science and engineering ethics · 2019Article
- Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals.World journal of surgery · 2014Article
- The unbearable lightness of health science reporting: a week examining Italian print media.PloS one · 2010Article
- Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2010Article
- Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents.PloS one · 2008Article
- Improving the use of research evidence in guideline development: 4. Managing conflicts of interests.Health research policy and systems · 2006Article
- Growth and decentralization of the medical literature: implications for evidence-based medicine.Journal of the Medical Library Association : JMLA · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.